MEGF10 inhibitors represent a specific category of chemical compounds that have gained significance in the field of molecular biology and cellular research. MEGF10, or Multiple Epidermal Growth Factor-like Domains 10, is a protein that belongs to the MEGF family, known for its distinctive structure comprising multiple epidermal growth factor-like domains. The term MEGF10 inhibitors refers to a class of molecules meticulously designed to selectively target and modulate the activity of MEGF10. These inhibitors serve as valuable tools in laboratory investigations, aiding researchers in exploring the intricate molecular functions and cellular processes associated with MEGF10.
MEGF10 inhibitors typically function by interacting with the MEGF10 protein or its associated molecules, thereby altering its normal biochemical activities. This interference can lead to the modulation of cellular processes and signaling pathways influenced by MEGF10, impacting various aspects of cellular biology. Scientists employ MEGF10 inhibitors to delve into the physiological roles and molecular interactions of MEGF10 within cells, aiming to advance our comprehension of the fundamental cellular processes and mechanisms in which MEGF10 is involved. Through the study of MEGF10 inhibitors, researchers seek to unravel the complexities of cellular signaling networks and gain novel insights into the biology of MEGF10, its potential roles in cellular homeostasis, and its broader implications in cellular function and regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound can cause DNA demethylation and might alter the expression of various genes, potentially including those coding for MEGF10. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid is another HDAC inhibitor that might change gene expression patterns and could potentially downregulate MEGF10. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
This compound is incorporated into RNA and DNA and can interfere with nucleotide synthesis and gene expression, potentially impacting MEGF10. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate interferes with folate metabolism, which could indirectly impact gene expression and potentially downregulate MEGF10. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates DNA and inhibits RNA polymerase action, which could decrease transcription of genes, potentially including MEGF10. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid affects gene expression by activating nuclear receptors, which could influence the regulatory pathways of MEGF10. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine is a DNA methyltransferase inhibitor that can cause hypomethylation of DNA and alter gene expression, possibly affecting MEGF10. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a CDK inhibitor that may alter cell cycle-dependent gene expression, potentially reducing MEGF10 levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
It is an mTOR inhibitor that can downregulate protein synthesis and might influence the expression of proteins such as MEGF10. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat is an HDAC inhibitor that can lead to changes in gene expression, potentially affecting the transcription of MEGF10. | ||||||